Spruce Biosciences has named Dale…
Spruce Biosciences has named Dale Hooks as chief commercial officer, [...]
Bristol Myers Squibb’s…
Bristol Myers Squibb’s mezigdomide has scored its first phase 3 [...]
Xenon Pharmaceuticals’…
Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out [...]
Shanghai-based Tenacia…
Shanghai-based Tenacia Biotechnology is making a $308 million biobucks move [...]
After a tumultuous tenure marked…
After a tumultuous tenure marked by recent clashes with the [...]
Under the deal with Lone Star…
Under the deal with Lone Star Funds, Lonza maintains a [...]
Sen. Ron Wyden of Oregon is going…
Sen. Ron Wyden of Oregon is going straight to drugmakers [...]
Sanofi has agreed to sell its…
Sanofi has agreed to sell its Medley generics unit in [...]
Almost all of last month’s top…
Almost all of last month’s top 10 pharma TV ad [...]
The three-pronged plan to…
The three-pronged plan to strengthen domestic drug supply will be [...]